These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: The Impact of Allocation Changes on Patients with Hepatocellular Carcinoma.
    Author: Yohanathan L, Heimbach JK.
    Journal: Clin Liver Dis; 2020 Nov; 24(4):657-663. PubMed ID: 33012451.
    Abstract:
    Since the establishment of the Milan criteria, liver transplantation (LT) has been identified as an optimal therapy for selected patients with early stage, unresectable hepatocellular carcinoma (HCC) complicating cirrhosis, although a major limitation is the critical shortage of available deceased donor liver allografts. This review focuses on the evolution of liver allocation for HCC in the United States and what the most recent revisions to the allocation system mean for patients with HCC.
    [Abstract] [Full Text] [Related] [New Search]